Effects of mifepristone on the human endometrium and the fallopian tube during the luteal phase
Author: Sun, Xiaoxi
Date: 2005-06-09
Location: Skandiasalen, Astrid Lindgrens Barnsjukhus, Karolinska Universitetssjukhuset, Solna
Time: 10.00
Department: Institutionen för kvinnors och barns hälsa / Department of Women's and Children's Health
View/ Open:
Thesis (1.160Mb)
Abstract
Mifepristone given postovulatory has been shown effective for contraception, but the precise mechanism of action is still poorly understood. A better understanding of the mechanisms of action of mifepristone, when used for contraception, is important for further development and optimizing the regimen of use.
To study the effects of mifepristone during the luteal phase, a single dose of 200mg mifepristone was administered on day LH+2. Endometrial biopsies were obtained on day LH+6 to LH+8 (the expected time for endometrial receptivity and implantation) and the fallopian tube on day LH+4 to LH+6 (approximately the time when the embryo is still in the fallopian tube). Immunohistochemistry, RT-PCR and Western blot were used for analysis of the endometrium and the fallopian tube samples.
After treatment with mifepristone, progesterone receptor isoform B (PR-B) concentrations increased in glandular cells of the endometrium and in epithelial and stromal cells in the fallopian tube. In the endometrium endothelial nitric oxide synthase (eNOS) expression was attenuated in the glandular epithelium, in contrast to endothelial eNOS, which was not changed. The expression of insulin-like growth factor binding protein-1 (IGFBP-1) was significantly increased in the glandular epithelial cells. The staining intensity of heparin-binding epidermal growth factor-like growth factor (HB-EGF) was not affected by mifepristone.
Treatment with mifepristone increased the immunostaining of HB-EGF receptor HER1 in the epithelium and the stroma in the endometrium, while the opposite was seen in the luminal epithelium of the fallopian tube. The immunostaining of HB-EGF receptor HER4 increased in the epithelial cells of the endometrium, while a decrease was seen in the stroma of the fallopian tube.
In conclusion these results indicate that mifepristone administered immediately after ovulation has pronounced effects on the endometrium at the expected time of endometrial receptivity. These changes may contribute to cause defective endometrial receptivity and altered intraluminal milieu. The effect on the fallopian tube may also be of importance for the contraceptive effect of mifepristone.
To study the effects of mifepristone during the luteal phase, a single dose of 200mg mifepristone was administered on day LH+2. Endometrial biopsies were obtained on day LH+6 to LH+8 (the expected time for endometrial receptivity and implantation) and the fallopian tube on day LH+4 to LH+6 (approximately the time when the embryo is still in the fallopian tube). Immunohistochemistry, RT-PCR and Western blot were used for analysis of the endometrium and the fallopian tube samples.
After treatment with mifepristone, progesterone receptor isoform B (PR-B) concentrations increased in glandular cells of the endometrium and in epithelial and stromal cells in the fallopian tube. In the endometrium endothelial nitric oxide synthase (eNOS) expression was attenuated in the glandular epithelium, in contrast to endothelial eNOS, which was not changed. The expression of insulin-like growth factor binding protein-1 (IGFBP-1) was significantly increased in the glandular epithelial cells. The staining intensity of heparin-binding epidermal growth factor-like growth factor (HB-EGF) was not affected by mifepristone.
Treatment with mifepristone increased the immunostaining of HB-EGF receptor HER1 in the epithelium and the stroma in the endometrium, while the opposite was seen in the luminal epithelium of the fallopian tube. The immunostaining of HB-EGF receptor HER4 increased in the epithelial cells of the endometrium, while a decrease was seen in the stroma of the fallopian tube.
In conclusion these results indicate that mifepristone administered immediately after ovulation has pronounced effects on the endometrium at the expected time of endometrial receptivity. These changes may contribute to cause defective endometrial receptivity and altered intraluminal milieu. The effect on the fallopian tube may also be of importance for the contraceptive effect of mifepristone.
List of papers:
I. Sun X, Christow A, Marions L, Gemzell-Danielsson K (2003). Progesterone receptor isoform B in the human fallopian tube and endometrium following mifepristone. Contraception. 67(4): 319-26.
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Sun X, Qiu X, Gemzell-Danielsson K (2003). Effects of mifepristone on expression of endothelial nitric oxide synthase in human endometrium during the implantation phase. Fertil Steril. 80(6): 1454-60.
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. Qiu X, Sun X, Christow A, Stabi B, Gemzell-Danielsson K (2002). The effect of mifepristone on the expression of insulin-like growth factor binding protein-1, prolactin and progesterone receptor mRNA and protein during the implantation phase in human endometrium. Mol Hum Reprod. 8(11): 998-1004.
Fulltext (DOI)
Pubmed
View record in Web of Science®
IV. Sun X, Gemzell-Danielsson K, Li H, Stabi B, Stavreus-Evers A (2005). Expression of heparin-binding epidermal growth factor-like growth factor and its receptors in the human fallopian tube and endo,etrium after treatment with mifepristone. [Submitted]
I. Sun X, Christow A, Marions L, Gemzell-Danielsson K (2003). Progesterone receptor isoform B in the human fallopian tube and endometrium following mifepristone. Contraception. 67(4): 319-26.
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Sun X, Qiu X, Gemzell-Danielsson K (2003). Effects of mifepristone on expression of endothelial nitric oxide synthase in human endometrium during the implantation phase. Fertil Steril. 80(6): 1454-60.
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. Qiu X, Sun X, Christow A, Stabi B, Gemzell-Danielsson K (2002). The effect of mifepristone on the expression of insulin-like growth factor binding protein-1, prolactin and progesterone receptor mRNA and protein during the implantation phase in human endometrium. Mol Hum Reprod. 8(11): 998-1004.
Fulltext (DOI)
Pubmed
View record in Web of Science®
IV. Sun X, Gemzell-Danielsson K, Li H, Stabi B, Stavreus-Evers A (2005). Expression of heparin-binding epidermal growth factor-like growth factor and its receptors in the human fallopian tube and endo,etrium after treatment with mifepristone. [Submitted]
Issue date: 2005-05-19
Rights:
Publication year: 2005
ISBN: 91-7140-346-9
Statistics
Total Visits
Views | |
---|---|
Effects ...(legacy) | 664 |
Effects ... | 146 |
Total Visits Per Month
September 2023 | October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | |
---|---|---|---|---|---|---|---|
Effects ... | 0 | 2 | 0 | 0 | 1 | 0 | 0 |
File Visits
Views | |
---|---|
thesis.pdf(legacy) | 910 |
thesis.pdf | 324 |
thesis.pdf.txt(legacy) | 2 |
Top country views
Views | |
---|---|
United States | 376 |
China | 76 |
Germany | 57 |
Sweden | 55 |
Russia | 17 |
South Korea | 14 |
United Kingdom | 11 |
Finland | 7 |
Denmark | 6 |
Hong Kong | 6 |
Top cities views
Views | |
---|---|
Ashburn | 41 |
Beijing | 41 |
Sunnyvale | 30 |
Romeo | 28 |
Kiez | 18 |
Seoul | 14 |
Des Moines | 7 |
Ballerup | 6 |
Dublin | 6 |
London | 6 |